Schering Health Care to use Profile inhaler
This article was originally published in Clinica
Executive Summary
Schering Health Care, a UK division of German pharmaceutical and diagnostics group Schering AG, is to use an "intelligent" inhaler developed by Profile Therapeutics. The Bognor Regis, UK firm's Prodose device will be used with Schering's recently approved Ventavis medicine for primary pulmonary hypertension, a rare disorder with around 200 sufferers in the UK and about 2,000 in Europe.